BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 37642945)

  • 1. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
    Fernandes DA
    Technol Cancer Res Treat; 2023; 22():15330338231191493. PubMed ID: 37642945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive theranostic system: A promising approach for augmented multimodal imaging and efficient drug release.
    Demiral A; Goralı Sİ; Yılmaz H; Verimli N; Çulha M; Erdem SS
    Eur J Pharm Biopharm; 2022 Aug; 177():9-23. PubMed ID: 35671914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Liganded Gold Nanoclusters as Efficient Theranostic Agents for Cancer Applications.
    Bonačić-Koutecký V; Le Guével X; Antoine R
    Chembiochem; 2023 Feb; 24(4):e202200524. PubMed ID: 36285807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Perspective in Cancer Theranostics Based on Gold Nanoparticles.
    Chatterjee S; Liang F
    Anticancer Agents Med Chem; 2022; 22(13):2354-2357. PubMed ID: 35196973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization of Metal and Carbon Nanoparticles with Potential in Cancer Theranostics.
    Mauro N; Utzeri MA; Varvarà P; Cavallaro G
    Molecules; 2021 May; 26(11):. PubMed ID: 34064173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hetero-Core-Shell BiNS-Fe@Fe as a Potential Theranostic Nanoplatform for Multimodal Imaging-Guided Simultaneous Photothermal-Photodynamic and Chemodynamic Treatment.
    Ma S; Xie J; Wang L; Zhou Z; Luo X; Yan J; Ran G
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10728-10740. PubMed ID: 33645960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart magnetic resonance imaging-based theranostics for cancer.
    Brito B; Price TW; Gallo J; Bañobre-López M; Stasiuk GJ
    Theranostics; 2021; 11(18):8706-8737. PubMed ID: 34522208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
    Yu Y; Mok BY; Loh XJ; Tan YN
    Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer.
    Liu M; Anderson RC; Lan X; Conti PS; Chen K
    Med Res Rev; 2020 May; 40(3):909-930. PubMed ID: 31650619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors.
    Li Z; Liu J; Hu Y; Li Z; Fan X; Sun Y; Besenbacher F; Chen C; Yu M
    Biomaterials; 2017 Oct; 141():284-295. PubMed ID: 28709019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy.
    Kawasaki R; Kondo K; Miura R; Yamana K; Isozaki H; Shimada R; Kawamura S; Hirano H; Nishimura T; Tarutani N; Katagiri K; Stubelius A; Sawada SI; Sasaki Y; Akiyoshi K; Ikeda A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT and MRI Imaging of Theranostic Bimodal Fe
    Lipengolts AA; Finogenova YA; Skribitsky VA; Shpakova KE; Anaki A; Motiei M; Semkina AS; Abakumov MA; Smirnova AV; Grigorieva EY; Popovtzer R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle Diagnostics and Theranostics in the Clinic.
    Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
    J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-templated platinum (II) sulfide nanodots for size-dependent cancer theranostics.
    Li M; Wang Y; Li T; Zhang J; Wang X; Luo J; You M; Yang T; Deng Y; Yang H; Ke H
    Acta Biomater; 2023 Jan; 155():564-574. PubMed ID: 36328127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fast-growing field of photo-driven theranostics based on aggregation-induced emission.
    Zhang Z; Kang M; Tan H; Song N; Li M; Xiao P; Yan D; Zhang L; Wang D; Tang BZ
    Chem Soc Rev; 2022 Mar; 51(6):1983-2030. PubMed ID: 35226010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.